Taxol®, which is also known as paclitaxel, is a chemotherapeutic agent widely used to treat
different cancers. Since the discovery of its antitumoral activity, Taxol® has been used to …

Toll-like receptors (TLRs) activation enables host to recognize a large number of pathogen-
associated molecule patterns (PAMPs), ignite immune cells to discriminate between self and …

Breast cancer (BC) is the second most fatal disease and is the prime cause of cancer allied
female deaths. BC is caused by aberrant tumor suppressor genes and oncogenes regulated …

Toll-like receptors (TLRs) are a family of transmembrane receptors that recognize various
pathogen-and damage-associated molecular pattern molecules playing an important role in …

MicroRNAs (miRNAs) are critical mediators of posttranscriptional regulation via their
targeting of the imperfect antisense complementary regions of coding and non-coding …

Emerging evidence suggests that cytotoxic therapy may actually promote drug resistance
and metastasis while inhibiting the growth of primary tumors. Work in preclinical models of …

Toll-like receptors (TLRs) belong to a class of pattern-recognition receptors that play an
important role in host defense against pathogens by recognizing a wide variety of pathogen …

There is evidence supporting the hypothesis that inflammation participates in providing
conditions that lead to cancer. An unresolved inflammation due to any failure in the precise …

Awareness of the importance of immunity in controlling cancer development triggered
research into the impact of its key oncogenic drivers on the immune response, as well as …

Cancer immunotherapy has been the focus of intense research since the late 19th century
when Coley observed that bacterial components can contribute to cancer regression by …